#121
|
||||
|
||||
À.Ñ.! À ãäå Âû ñëûøàëè î ïðîâåäåíèè ñèñòåìíîãî ôèáðèíîëèçà áåç ïåðâè÷íîãî ðàäèîëîãi÷åñêîãî ïîäòâåðæäåíèÿ íàëè÷èÿ òðîìáà?  ñåìèíàëüíîé ñòàòüå íåîáõîäèìûì ïðåðåêâåçèòîì ÿâëÿëàñü ÊÒÀ...
|
#122
|
|||
|
|||
Ñïåöèôèêà ìîåé íûíåøíåé ðàáîòû íåìíîãî íå ðàñïîëàãàåò ê ñèñòåìíîìó ôèáðèíîëèçó - ïîñëåäíèé ãîä òðóæóñü â íåéðîõèðóðãèè. Òåì íå ìåíåå, áûëî íåñêîëüêî ñëó÷àåâ çà ïîñëåäíèå ïàðó ëåò, â ò.÷. è â ïðîöåññå ðåàíèìàöèè.
 ñëó÷àå êëèíè÷åñêîãî ïîäîçðåíèÿ íà ÒÝËÀ, äåéñòâîâàòü çà÷àñòóþ ïðèõîäèòñÿ èìåííî "âñëåïóþ". Íå ïðèïîìíþ ñëó÷àåâ, ÷òîáû áîëüíûì ñ âåðîÿòíîé ìàññèâíîé âåíîçíîé ýìáîëèåé óäàâàëîñü â áëèæàéøåå âðåìÿ âûïîëíèòü ÊÒ- èëè îáû÷íóþ àíãèîãðàôèþ. ïî ïðè÷èíå êðàéíåé íåñòàáèëüíîñòè ïàöèåíòîâ. Åñëè æå áîëüíîé íàñòîëüêî ñòàáèëåí. ÷òî ìîæåò ïåðåæèòü òðàíñïîðòèðîâêó äî òîìîãðàôà/àíãèîãðàôà, òî ñ áîëüøîé âåðîÿòíîñòüþ îí ïîïðàâèòñÿ è áåç ñèñòåìíîãî ôèáðèíîëèçà. Íó ìîæåò áûòü çäåñü åùå èìååò çíà÷åíèå îðãàíèçàöèÿ ïðîöåññà - ó íàñ ôëàêîí÷èê ñ àëüòåïëàçîé âñåãäà íàãîòîâå äëÿ ñèñòåìíîãî ôèáðèíîëèçà ó áîëüíûõ ñ èøåìè÷åñêèì èíñóëüòîì. |
#123
|
||||
|
||||
Ïîâòîðèë âîïðîñ Ì.Þ.... Ñîððè. Áîëüíûå íå äàþò âîçìîæíîñòè íîðìàëüíîãî îáøåíèÿ...
|
#124
|
|||
|
|||
Âîò, íàïðèìåð, âûäåðæêè èç äîâîëüíî èçâåñòíîé êíèãè ïî ñïåöèàëüíîñòè, Paul L Marino, The ICU Book 3 (2007)
Spiral CT Angiography Spiral (helical) computed tomography (spiral CT) is a technique where the detector is rotated around the patient to produce a volumetric two-dimensional view of the lungs (32). (This differs from conventional CT, where the detector is moved in increments along the thorax to create two-dimensional “slices” of the lungs.) This procedure is completed in about 30 seconds. There must be no lung motion during the procedure, which means that patients must be able to breath-hold for 30 seconds to perform a spiral CT scan (32). This excludes patients who are ventilator-dependent or are unable to follow commands. Spiral CT has been performed on a few ventilator-dependent patients using continuous positive airways pressure (CPAP) combined with heavy sedation to inhibit chest wall movements (33), but the safety and reliability of this approach has not been validated in large numbers of patients. ... Pulmonary Angiography Pulmonary angiography, still considered the most accurate method for detecting pulmonary emboli, is performed in fewer than 15% of cases of suspected pulmonary embolism (36). Considering the array of other diagnostic modalities, the low rate of pulmonary angiography seems justified. |
#125
|
||||
|
||||
Öèòàòà:
Êîíå÷íî, ñåé÷àñ îáñóæäåíèå ïðàâèëüíîñòè ëå÷åíèÿ ïðîâîäèòñÿ ðåòðîñïåêòèâíî, ñîîòâåòñòâåííî ëèøåíî àæèîòàæà â îòñóñòâèè ëèìèòà âî âðåìåíè íà ïðèíÿòèå ðåøåíèé. Îäíàêî, çà ñåáÿ ìîãó ñêàçàòü îïðåäåëåííî, ÷òî ìíå íå ïðèøëî áû â ãîëîâó äåëàòü ÒËÒ ó áîëüíîãî ñ îòñóñòâèåì ñîçíàíèÿ íè ïðè êàêèõ ðàñêëàäàõ. Õîòÿ â îôèöèàëüíûõ ïðîòèâîïîêàçàíèÿõ ýòîò ïóíêò, êàê áû, îòñóñòâóåò. Ìîæíî îáñóäèòü ýòó òåìó ïîäðîáíåå, åñëè åñòü èíòåðåñ. Öèòàòà:
Öèòàòà:
To FRSM. ×òî êàñàåòñÿ ñèñòåìíîãî ÒËÒ ó áîëüíûõ ñ ÒÝËÀ, ïðè íàëè÷èè äîñòàòî÷íûõ êëèíè÷åñêèõ îñíîâàíèé, ïðîöåäóðó âïîëíå ìîæíî ïðîâåñòè è áåç âåðèôèêàöèè òðîìáà. Îñïîðüòå. |
#126
|
||||
|
||||
Ñïàñèáî çà èíôî. Íèêîãäà íå ó÷èòå ðàäèîëîãèþ ïî íåïðåäìåòíûì ðóêîâîäñòâàì - ïðàâèëî ñïàñ¸ò îò íåïðèÿòíûõ ñèòóàöèé.
Êîãäà ìíå íóæíà õèðóðãè÷åñêàÿ òåìà, íèêîãäà íå ñìîòðþ ðàäèîëîãè÷åñêóþ êíèãó, ò.ê. òàì ìíîãî íåïðàâèëüíîãî. Ïðàâèëî ïåðåíîøó íà ÂÑÅ íàïðàâëåíèÿ. |
#127
|
||||
|
||||
"ïðîöåäóðó âïîëíå ìîæíî ïðîâåñòè è áåç âåðèôèêàöèè òðîìáà. Îñïîðüòå."
Äîêàæèòå. |
#128
|
||||
|
||||
Öèòàòà:
îäèí èç êîòîðûõ òàêîâ, ìîæåò ëè âíóòðè÷åðåïíîå êðîâîèçëèÿíèå "óñêîëüçíóòü" èç âèäà íà ÊÒ? Âîçìîæíî ïðèçíàêè åãî ñòåðòû èëè çàìàñêèðîâàíû îòåêîì? ïîïàëàñü íà ãëàçà ñòàòüÿ óêðàèíñêèõ êîëëåã, íå ìîãó îöåíèòü åå öåííîñòü, íî èíôîðìàöèÿ â íåé äîñòàòî÷íî èíòåðåñíàÿ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] îñîáåííî çàèíòåðåñîâàëè ìîìåíòû: ...Ñðåäè ïðè÷èí ñìåðòè ïàöèåíòîâ ñ ìîçãîâûì èíñóëüòîì íà âòîðîì ìåñòå ïîñëå èíòðàöåðåáðàëüíûõ (äèñëîêàöèîíûé ñèíäðîì, îòåê ãîëîâíîãî ìîçãà, âòîðè÷íûé ñòâîëîâîé ñèíäðîì, îñòðàÿ îêêëþçèîííàÿ ãèäðîöåôàëèÿ) ñòîÿò êàðäèàëüíûå è ïóëüìîíàëüíûå îñëîæíåíèÿ. Ãëàâíûìè è íàèáîëåå ÷àñòûìè èç íèõ ÿâëÿþòñÿ íàðóøåíèÿ ñåðäå÷íîãî ðèòìà (ñóïðàâåíòðèêóëÿðíûå àðèòìèè, ýêñòðàñèñòîëèè, áðàäèêàðäèè âïëîòü äî ñèíîàòðèàëüíîé è àòðèîâåíòðèêóëÿðíîé áëîêàä, ôèáðèëëÿöèÿ æåëóäî÷êîâ), îñòðûé èíôàðêò ìèîêàðäà (ÎÈÌ) è íåâðîãåííûé îòåê ëåãêèõ... ...Ïðè îïðåäåëåíèè óðîâíÿ òðîïîíèíà ² ó áîëüíûõ ñ ðàçëè÷íûìè òèïàìè èíñóëüòà ïîëó÷åíû ñëåäóþùèå ðåçóëüòàòû: – ó ïàöèåíòîâ ñ ÈÈ òðîïîíèí ² îïðåäåëÿëñÿ â 66,7% ñëó÷àåâ, íî åãî óðîâíè áûëè íåâûñîêèìè (0,4-1,1 íã/ìë); – ó ïàöèåíòîâ ñ ãåìîððàãè÷åñêèì èíñóëüòîì âûÿâëåíî ïîâûøåíèå óðîâíÿ òðîïîíèíà ² â 88,7% ñëó÷àåâ (0,4-6,8 íã/ìë); – ó áîëüíûõ ñ ñóáàðàõíîèäàëüíûìè êðîâîèçëèÿíèÿìè óðîâåíü òðîïîíèíà ² ïîâûøàëñÿ íàèáîëåå ÷àñòî (93,7% ïàöèåíòîâ, 0,5-4,3 íã/ìë)... ê ñîáñòâåííîìó ñòûäó ñêàæó, ÷òî àíãëîÿçû÷íûå ñòàòüè äàþòñÿ ñ áîëüøèì òðóäîì, òàê ÷òî åñëè ÿ ïîâòîðÿþ óæå ïðèâåäåííûå èíîñòðàííûå ññûëêè-èçâèíÿþñü. |
#129
|
|||
|
|||
Öèòàòà:
Âîò, íàïðèìåð èíòåðåñíàÿ ññëûêà - http://ats.ctsnetjournals.org/cgi/co...full/67/6/1785 - ó ýòèõ ðåáÿò õâàòèëî îòâàãè ïðîâåñòè ôèáðèíîëèç ïàöèåíòó ñïóñòÿ äâîå ñóòîê ïîñëå ëîáýêòîìèè è íà ôîíå îñòàíîâêè ñåðäöà. Ïàöèåíòó ïîñëå ýòîãî ïðèøëîñü ïåðåëèòü 21 ïàêåò ñ äîíîðñêîé êðîâüþ, íî âûïèñàëñÿ ñ õîðîøèì íåâðîëîãè÷åñêèì èñõîäîì è ôóíêöèîíàëüíûì ñòàòóñîì. Ïðàâäà îäèí íþàíñ, äî òîãî, êàê ïàöèåíò îñòàíîâèëñÿ, åìó óñïåëè âûïîëíèòü àíãèîïóëüìîíîãðàôèþ .. |
#130
|
|||
|
|||
Öèòàòà:
Äëÿ òîãî. ÷òîáû ïàöèåíòó âîçìîæíî áûëî âûïîëíèòü ÊÒ-àíãèîãðàôèþ, îí äîëæåí áûòü äîñòàòî÷íî ñòàáèëåí, ÷òîáû ïåðåíåñòè òðàíñïîðòèðîâêó (åñòü ðèñê, ÷òî îí çíà÷èìî óõóäøèòñÿ ïî äîðîãå) è äîëæåí áûòü äîñòàòî÷íî ñòàáèëåí, ÷òîáû ïåðåíîñèòü õîòÿ áû 30-ñåêóíäíûå çàäåðæêè äûõàíèÿ âî âðåìÿ èññëåäîâàíèÿ. |
#131
|
|||
|
|||
Öèòàòà:
Ïðè òÿæåëîé âíóòðè÷åðåïíîé ãèïåðòåíçèè, êàê ïðàâèëî, õàðàêòåðåí âûðàæåííûé ïîäúåì ÀÄ, ïî êðàéíåé ìåðå, íà ïåðâûõ ïîðàõ. |
#132
|
|||
|
|||
THE AMERICAN JOURNAL OF CARDIOLOGY, 15 March 2009
Diagnosis of Pulmonary Embolism in the Coronary Care Unit The clinical diagnosis of pulmonary embolism (PE) is difficult in coronary care units (CCUs) because many findings of PE are similar to those of acute coronary syndromes and heart failure. Immobilization of only 1 or 2 days may predispose to PE. Heart failure and acute myocardial infarction add to the risk. Dyspnea may be absent or occur only with exertion. The onset of dyspnea may occur over seconds to days. Orthopnea occurs with PE as well as heart failure. When the clinical probability and results of objective testing are discordant, the posttest probability of PE may be neither sufficiently high nor sufficiently low to permit therapeutic decisions. Objective scoring systems for clinical assessment have not been developed for patients in a CCU. d-dimer is likely to be of little value for the exclusion of PE in CCUs, because elevations occur with heart failure, unstable angina, and myocardial infarction. Computed tomographic pulmonary angiography with venous phase imaging of the low pelvic and proximal leg veins (computed tomographic venography) is recommended for imaging. Scintigraphy in women aged <50 years with normal or nearly normal results on chest x-ray may be the preferred imaging test to reduce the risk for radiation. Echocardiography with leg ultrasonography is a rapidly obtainable combination of bedside tests that may be useful for young patients and patients in extremis. In conclusion, the choice of diagnostic test depends on the clinical probability of PE, the condition of the patient, the availability of diagnostic tests, the risks of iodinated contrast material, radiation exposure, and cost. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ïîëíûé òåêñò: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#133
|
|||
|
|||
Ó íàñ èçðåäêà áûâàåò: õîòÿ ÿ è íå çàíèìàþñü ðåàíèìàöèåé, íî èçðåäêà íàì ïîïàäàþòñÿ íà íàøè ðàçáîðû ïîäîáíûå ïàöèåíòû. B ñèòóàöèè ñ ïîäîçðåíèåì íà ìàññèâíûé ë¸ãî÷íûé ýìáîëèçì è íåóñïåøóþ ðåàíèìàöèþ òðîìáîëèçèñ ìîãóò íà÷àòü è âî âðåìÿ ðåàíèìàöèîííûõ ìåðîïðèÿòèé íà ýòàæå (õîòÿ îáû÷íî ýòî äåëàåòñÿ óæå â ðåàíèìàöèè), òê ýõîêàðäèîãðàììà â òàêèõ ñëó÷àÿõ äåëàåòñÿ òàì æå (èëè íåìåäëåííî ïî ïðèáûòèè â ðåàíèìàöèþ) - è åñëè ïîäîçðåíèå âûñîêîå, èëè ïîäòâåðæäàþò , òî âîïðîñ î ïðîâåäåíèè òðîìáîëèçèñà, ïî êðàéíåé ìåðå, ìîãóò ïîäíÿòü ñðàçó. À óæ àíòèêîàãóëÿöèîííóþ òåðàïèþ íà÷íóò îáÿçàòåëüíî ïðè ñèëüíîì ïîäîçðåíèè íà ÒÝËÀ (â ïîñëåäíåå âðåìÿ, ïðàâäà, ñòàâÿò êàâàëüíûå ôèëüòðû õèðóðãè÷åñêèì ïàöèåíòàì). Åñòåñòâåííî, âñ¸ ýòî äåëàåòñÿ ïîñëå ñðî÷íîãî îáñóæäåíèÿ ñ õèðóðãîì. Òåì áîëåå îïåðàöèÿ ó äàííîé ïàöèåíòêè áûëà çà 2 äíÿ äî ñîáûòèÿ, è îïåðàöèÿ íå íåéðîõèðóðãè÷åñêàÿ, òå â ïðèíöèïå ðèñêíóòü ñòîèëî. Ê ñîæàëåíèþ, ñóäÿ ïî èñõîäíîé èíôîðìàöèè (òî÷íåå, îáðûâêàì èíôîðìàöèè), ðåàíèìàöèîííûå ìåðîïðèÿòèÿ áûëè ïðîâåäåíû, ñêîðåå âñåãî, íåàäåêâàòíî (åñëè äàæå êèñëîðîäà íå áûëî). Êîíå÷íî, ëåãêî êèäàòü êàìíè, ñèäÿ ãäå-òî äàëåêî-äàëåêî, íî, ñîãëàñèòåñü, ÷òî íåÿñíîñòåé (òàê ñêàçàòü) - îãðîìíîå êîëè÷åñòâî. Êñòàòè, ïî ïîâîäó êàííþëÿöèè öåíòðàëüíîé âåíû: âî âðåìÿ ðåàíèìàöèîííûõ ìåðîïðèÿòèé íà ýòàæå ó íàñ ñêîðåå âñåãî ïîñòàâèëè áû áåäðåííóþ, ÷òîáû íå ïðåðûâàòü íåïðÿìîé ìàññàæ ñåðäöà.
Êñòàòè, Vlad34 äàë ìíå 3 ññûëêè íà îòäàë¸ííûé ãàçîâûé ýìáîëèçì (ÿ åù¸ íå âñå ïðî÷ëà, òàê ÷òî ýòó òåìó áóäó êîììåíòèðîâàòü ïîçæå); ïîñëåäíÿÿ ññûëêà - ýòî ñëó÷àé ìàññèâíîé ÒÝËÀ (êàê ñàìè àâòîðû è ñäåëàëè âûâîä) íà ïåðâûé ïîñëåîïåðàöèîííûé äåíü ïîñëå ëàïàðîñêîïè÷åñêîé êîëýêòîìèè, è ïàöèåíòó ïðîâåëè òðîìáîëèçèñ ñðàçó æå, ÷òî ïîçâîëèëî âûïèñàòü åãî èç ðåàíèìàöèè íà 7å ñóòêè, à ïîòîì è äîìîé. Õîòÿ òàì òîæå ïðîâåëè ñêàíèðîâàíèå ñíà÷àëà, íî è ñèòóàöèÿ ñ êëèíèêîé íå áûëà òàêîé äðàìàòè÷åñêîé, êàê â äàííîì ñëó÷àå. |
#134
|
|||
|
|||
Diagnostic Pathways in Acute Pulmonary Embolism
The American Journal of Medicine, December 2006 Ïîëíûé òåêñò: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#135
|
||||
|
||||
Öèòàòà:
ìåíÿ èíòåðåñóåò,íàñêîëüêî èíôîðìàòèâíî ÊÒ,âûïîëíåííîå íà 4-å ñóòêè îò íà÷àëà "êàòàñòðîôû", íàïðèìåð ïðè ñóáàðàõíîèäàëüíîì êðîâîèçëèÿíèè. Åñëè ýòîò ìåòîä äàåò 100% èñêëþ÷åíèå äàííîãî äèàãíîçà,òî î íåì çàáûâàåì è ïðîäîëæàåì îáñóæäàòü òðîìáîëèçèñ è òä. |